The FBX12 antibody is a specialized immunological tool designed to detect and study the F-box/LRR-repeat protein 12 (FBX12), a member of the F-box protein family. F-box proteins are critical components of the Skp1-Cullin-F-box (SCF) ubiquitin ligase complex, which governs substrate recognition for ubiquitination and subsequent proteasomal degradation. FBX12 is implicated in diverse cellular processes, including cell cycle regulation, signal transduction, and protein homeostasis.
Key properties of commercially available FBX12 antibodies are summarized below:
| Parameter | Details |
|---|---|
| Target | FBX12 (F-box/LRR-repeat protein 12) |
| Host Species | Rabbit |
| Clonality | Polyclonal |
| Reactive Species | Arabidopsis thaliana (Mouse-ear cress) |
| Applications | ELISA, Western Blot (WB) |
| Immunogen | Recombinant Arabidopsis thaliana FBX12 protein |
| Storage | -20°C or -80°C; avoid repeated freeze-thaw cycles |
| Concentration | 1 mg/mL |
| Purification | Antigen affinity-purified |
| Formulation | Liquid (50% glycerol, 0.01M PBS, pH 7.4, 0.03% Proclin 300 preservative) |
FBX12 contains leucine-rich repeats (LRRs) and an F-box domain, enabling interactions with Skp1 and substrate recognition. While FBX12’s role in mammals remains understudied, its homologs in plants (e.g., Arabidopsis thaliana) are linked to stress responses and developmental regulation.
Western Blot: Validated in Arabidopsis lysates, detecting a band at ~37 kDa .
ELISA: Used for quantitative FBX12 detection in plant extracts .
Species Specificity: Current FBX12 antibodies are validated primarily in Arabidopsis thaliana, limiting mammalian research .
Therapeutic Potential: No direct studies link FBX12 to human pathologies, though F-box proteins are emerging targets in cancer immunotherapy .
Mechanistic Studies: Structural and functional analyses are needed to elucidate FBX12’s substrates and regulatory networks.
Methodological approach:
Perform immunogen alignment: Compare the recombinant FBX12 protein sequence (UniProt: P0C2C9) used as the immunogen with the target species' sequence using tools like BLAST or UniProt.
Use negative controls: Include knockout Arabidopsis thaliana lines or tissues with FBX12 knockdown to confirm signal absence .
Application-specific validation: For Western blot (WB), ensure the antibody detects the expected molecular weight (~25–30 kDa for FBX12). For ELISA, validate against recombinant FBX12 spiked into plant lysates .
Critical variables:
Sample preparation: FBX12’s intracellular localization may require denaturing conditions (e.g., SDS-PAGE for WB) to expose epitopes .
Cross-reactivity: Test for nonspecific binding using lysates from phylogenetically distant species (e.g., mammalian cells) .
Antibody dilution: Optimize using a checkerboard titration (e.g., 1:100–1:10,000) in preliminary experiments .
Comparative analysis:
Case example: A study comparing Fab and F(ab')₂ fragments of a Stx2-neutralizing antibody found dose-dependent differences in neutralization efficacy (e.g., 20 ng Fab vs. F(ab')₂) .
Root-cause analysis:
Avidity effects: Multivalent F(ab')₂ may exhibit higher target affinity than monovalent Fab .
Fc-independent mechanisms: Assess if FBX12 neutralization relies on Fc-mediated cellular uptake or direct epitope blocking .
Assay conditions: Compare pH, temperature, and co-factor requirements (e.g., divalent cations) .
Evidence-based recommendations:
Troubleshooting steps:
Technical considerations: